Although IL-17RA-mediated inflammation in liver cells serves an important role in liver diseases, most previous studies focused on the IL-17RA signaling in non-parenchymal cells such as KCs and HSCs and indicated that IL-17RA-deficient KCs and HSCs showed impaired activation in vivo in response to the DEN-induced liver injury (35). Here, IL17RA is linked to liver disorder.